title: Acute coronary syndrome (ACS) in patients with essential thrombocytemia (ET). What is the best treatment?
authors.affiliation: Cardiology Unit, Azienda Ospedaliera Santa Maria Nuova-IRCCS Reggio Emilia, Italy.
authors.forename: G
authors.initials: G
authors.lastname: Tortorella
authors.affiliation: Cardiology Unit, Azienda Ospedaliera Santa Maria Nuova-IRCCS Reggio Emilia, Italy. Electronic address: massimo.calzolari@asmn.re.it.
authors.forename: M
authors.initials: M
authors.lastname: Calzolari
authors.affiliation: Hematology Unit, Azienda Ospedaliera Santa Maria Nuova-IRCCS Reggio Emilia, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Tieghi
authors.affiliation: Cardiology Unit, Azienda Ospedaliera Santa Maria Nuova-IRCCS Reggio Emilia, Italy.
authors.forename: N
authors.initials: N
authors.lastname: Muià
authors.affiliation: Hematology Unit, San MaurizioRregional Hospital, Bolzano, South Tyrol, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Piccin
authors.affiliation: Hematology Institute L.e A. Serignoli S.Orsola Malpighi University Hospital, Bologna, Italy.
authors.forename: L
authors.initials: L
authors.lastname: Gugliotta
mesh_terms: D054058:Acute Coronary Syndrome / Q000209:etiology / Q000628:therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D013920:Thrombocythemia, Essential / Q000150:complications
keywords: Acute coronary syndrome; Anagrelide; Essential thrombocythemia